MeSH term
Frequency | Condition_Probility | Animals | 33 | 0.0 |
*Colorectal Neoplasms/diagnosis/metabolism/pathology/therapy | 2 | 3.0 |
Humans | 51 | 0.0 |
Amidohydrolases/*genetics | 2 | 16.0 |
Base Sequence | 5 | 0.0 |
CHO Cells | 3 | 0.0 |
COS Cells | 4 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Mice | 13 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Transfection | 6 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Catalysis | 4 | 0.0 |
Circular Dichroism | 2 | 0.0 |
Endocannabinoids | 19 | 79.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Rats | 17 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Female | 8 | 0.0 |
Lymphocytes/metabolism | 2 | 0.0 |
Receptors, Cannabinoid | 14 | 35.0 |
Receptors, Drug/agonists/metabolism | 2 | 50.0 |
Arachidonic Acids/metabolism | 4 | 10.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Substrate Specificity | 4 | 0.0 |
Amidohydrolases/antagonists & inhibitors/genetics/*metabolism | 3 | 100.0 |
Enzyme Inhibitors/pharmacology | 9 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Adult | 6 | 0.0 |
Cannabinoids/metabolism | 5 | 83.0 |
Pregnancy | 4 | 0.0 |
Arachidonic Acids/*metabolism | 6 | 18.0 |
Amidohydrolases/*metabolism | 4 | 50.0 |
Binding Sites | 3 | 0.0 |
Biological Transport | 5 | 0.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 2 | 1.0 |
In Vitro | 8 | 0.0 |
Tritium | 3 | 1.0 |
Amidohydrolases/antagonists & inhibitors/metabolism | 3 | 100.0 |
Arachidonic Acids/chemistry/*metabolism | 2 | 66.0 |
Binding, Competitive | 3 | 0.0 |
Biological Transport/drug effects | 5 | 2.0 |
*Receptor, Cannabinoid, CB2 | 5 | 83.0 |
Arachidonic Acids/*pharmacology | 2 | 11.0 |
Blotting, Western | 3 | 0.0 |
Dose-Response Relationship, Drug | 6 | 0.0 |
Glycerides/pharmacology | 2 | 33.0 |
Hydrolysis | 6 | 0.0 |
Protein Binding | 3 | 0.0 |
Receptors, Drug/antagonists & inhibitors | 2 | 100.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Amidohydrolases/antagonists & inhibitors/*metabolism | 2 | 100.0 |
Comparative Study | 9 | 0.0 |
Phenylmethylsulfonyl Fluoride/pharmacology | 2 | 12.0 |
Amidohydrolases/metabolism | 5 | 25.0 |
Cell Line, Tumor | 2 | 0.0 |
Endocannabinoids/*metabolism | 4 | 80.0 |
Kinetics | 5 | 0.0 |
Phosphonic Acids/pharmacology | 2 | 25.0 |
Time Factors | 3 | 0.0 |
Cats | 3 | 0.0 |
Adjuvants, Immunologic/pharmacology | 2 | 2.0 |
Receptors, Drug/metabolism | 4 | 20.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Aged | 2 | 0.0 |
Brain/enzymology | 2 | 1.0 |
Male | 9 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Amidohydrolases/*antagonists & inhibitors | 3 | 100.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Arachidonic Acids/*metabolism/pharmacology | 2 | 100.0 |
Rats, Wistar | 4 | 0.0 |
Furans/pharmacology | 2 | 22.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Calcium Channel Blockers/pharmacology | 2 | 2.0 |
Cells, Cultured | 2 | 0.0 |
Receptor, Cannabinoid, CB1/*metabolism | 2 | 66.0 |
Signal Transduction | 2 | 0.0 |
Cerebellum/cytology/metabolism | 2 | 13.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Cell Division | 3 | 0.0 |
Drug Design | 3 | 0.0 |
Fatty Acids, Unsaturated/*metabolism | 2 | 9.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Molecular Conformation | 2 | 0.0 |
Brain/metabolism | 3 | 0.0 |
Radioligand Assay | 2 | 0.0 |
